Myeloproliferative Disorders
📧 Sign up to get email alerts when something new happens for Myeloproliferative Disorders.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-19EMA Authorised: Inrebic (fedratinib dihydrochloride monohydrate) — Bristol Myers Squibb Pharma EEIG
The EMA authorises Inrebic (fedratinib dihydrochloride monohydrate) for myeloproliferative disorders, including primary myelofibrosis, with …
-
EMA approval · 2026-06-08EMA Authorised: Omjjara (Momelotinib dihydrochloride monohydrate) — GlaxoSmithKline Trading Services Limited
EMA authorises Omjjara (momelotinib dihydrochloride monohydrate) for myeloproliferative disorders with splenomegaly; orphan medicine status.
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Results: A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating CPI-0610 with and without ruxolitinib in hematologic and myeloproliferative malignancies; study complete…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021) [NA]
A hematology-focused clinical trial update for HEM-Profiling 2021, currently recruiting to explore chemogenomic profiling across multiple le…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Pathogenesis of Hematologic Malignancies
An update on an ongoing clinical trial exploring the pathogenesis of hematologic malignancies, with enrollment by invitation at the sponsor …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation [Phase 1]
Phase 1 clinical trial evaluating preemptive CIML NK cell therapy after hematopoietic stem cell transplantation in patients with acute myelo…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Registry of Older Patients With Cancer
This clinical trial registry entry from UNC Lineberger indicates an ongoing recruitment for a registry of older patients with cancer, includ…
-
EMA approval · 2025-05-12EMA Authorised: Omjjara (Momelotinib dihydrochloride monohydrate) — GlaxoSmithKline Trading Services Limited
The European Medicines Agency authorized Omjjara (momelotinib dihydrochloride monohydrate) for myeloproliferative disorders including myelof…
-
CLINICAL_TRIALS trial_result · 2023-05-10Clinical Trial Update: Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders [Phase 2]
Phase 2 clinical trial update on donor peripheral stem cell transplantation for patients with advanced hematologic cancers and related disor…
-
CLINICAL_TRIALS trial_result · 2022-11-03Clinical Trial Update: Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies [Phase 2]
Phase 2 clinical trial update on shorter course tacrolimus after non-myeloablative conditioning with related donor PBSCT and high-dose postt…
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow [Phase 2]
Phase 2 trial update on specialized blood cell transplants for cancers of the blood and bone marrow; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer [Phase 2, Phase 3]
Phase 2/Phase 3 trial evaluating combination chemotherapy with donor stem cell transplant for aplastic anemia and hematologic cancers; compl…
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor [Phase 2, Phase 3]
Clinical trial update on ATIR donor lymphocyte preparation for haploidentical stem cell transplantation; study terminated with posted result…
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: Bone Marrow Transplant in Treating Patients With Hematologic Cancers [Phase 2]
Phase 2 clinical trial update on bone marrow transplant for hematologic cancers (completed).
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant [Phase 2]
Phase 2 trial update on non-myeloablative conditioning for unrelated donor umbilical cord blood transplant completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter [Phase 3]
Phase 3 trial studying dalteparin to prevent complications in cancer patients receiving chemotherapy via a catheter completed.
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder [Phase 2]
Phase 2 trial evaluating arsenic trioxide, ascorbic acid, dexamethasone, and thalidomide in chronic myeloproliferative disorders, leukemia, …
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial [Phase 3]
Phase 3 clinical trial update focusing on personalized or basic information to aid decision-making for participating in a trial.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Treatment for Chronic Pain in Patients With Advanced Cancer [Phase 3]
Phase 3 clinical trial update for a treatment addressing chronic pain in patients with advanced cancer; status indicates completed.
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders [Phase 2]
Phase 2 trial update of an allogeneic hematopoietic cell transplant in hematologic cancers/disorders; status completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT [Phase 2]
Phase 2 clinical trial evaluating irradiation-based myeloablative conditioning followed by regulatory T cell and conventional T cell immunot…
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders [Phase 2]
Phase 2 clinical trial evaluating post-infusion allogeneic cytokine-induced killer (CIK) cells as consolidative therapy in myelodysplastic s…
-
CLINICAL_TRIALS trial_result · 2019-04-04Clinical Trial Update: PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated prophylaxis for graft-versus-host disease using post-transplant cyclophosphamide and ruxolitinib in pat…
-
CLINICAL_TRIALS trial_result · 2018-12-31Clinical Trial Update: Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers [Phase 2]
Phase 2 trial evaluating donor stem cell transplantation with sirolimus and treated immune cells, for blood and lymph cancers, terminated wi…
-
CLINICAL_TRIALS trial_result · 2018-09-26Clinical Trial Update: Experimental Bone Marrow Transplant Protocol [Phase 2]
Phase 2 clinical trial update for an experimental bone marrow transplant protocol that investigated treatment in blood cancer conditions; st…